Skip to main content
. 2018 May 25;9(6):637. doi: 10.1038/s41419-018-0685-8

Fig. 5. ANXA5 influences tumor formation and malignancy of Hca-P-bearing mice via CD34 and VEGF-3 in tumor body.

Fig. 5

CD34 level comparisons in primary tumors induced by Hca-P-ANXA5-shRNA1 and Hca-P-ANXA5-shControl transplantation in 10 and 21 d (a). CD34 expression decreased in tumors from Hca-P-ANXA5-shRNA1 bearing mice, which was more significant in 21 days following transplantation (P= 0.002, Table 4). VEGF3 changes in tumors from Hca-P-ANXA5-shRNA1- transplanted mice than Hca-P-ANXA5-shControl group in 10 and 21 d (b). Its level decreased in tumors from Hca-P-ANXA5-shRNA1 mice, which was more clear in 21 d following transplantation (P = 0.002, Table 4)